Hsia et al [33] investigated the survival time in advanced lung cancer patients using ANNs from the genetic polymorphism of the p21 and p53 genes in conjunction with patients' general data (gender, age, disease type and period of lung cancer, chemical diagnosis, treatment type of chemical diagnosis, smoking habit). The gene discussed is TP53; the disease is lung cancer.